Abdera Therapeutics logo

Abdera Therapeutics

36 employees · est. 2021 · South San Francisco, United...

VS
Anchiano Therapeutics logo

Anchiano Therapeutics

Dedicated to the discovery, development, and commercialization of novel targeted therapies to treat cancer

1 employees · est. 2004 · Cambridge, United States

Anchiano Therapeutics is the older company (2021 vs 2004); Abdera Therapeutics is the larger of the two.

Side-by-Side Comparison

Abdera Therapeutics Anchiano Therapeutics
Founded
2021 2004 older
Headquarters
South San Francisco, United States Cambridge, United States
Employees
36 larger 1
Industry
Biotechnology, Health Care, Life Sciences Biotechnology, Health Care, Medical Devices
Funding Stage
Series B Post Ipo Equity
Total Funding
$150.00M $42.00M
Funding Rounds
3 3
Services
Development of radiotherapeutic cancer treatments, Antibody engineering for targeted drug delivery, Drug discovery for radiopharmaceuticals, Clinical trials for novel cancer therapies Not tracked yet
Target Customers
Cancer patients (specifically SCLC and LCNEC), Healthcare providers, Oncologists, Pharmaceutical researchers Not tracked yet
Taxonomy
Precision Oncology, Targeted Radiation Therapies, Radioisotopes, Tumor Cell Destruction, Modular Technology Platform, Cancer Treatment, Innovative Drug Development, Team Growth, Medical Innovation, Cancer Therapy, Medical Technology, Cancer Research, Oncology Treatments Biopharmaceutical, Cancer Treatment, Targeted Therapies, Oncology Research, Drug Discovery, Clinical Trials, Precision Medicine
Website
abderatx.com anchiano.com
Abdera Therapeutics logo

About Abdera Therapeutics

Abdera Therapeutics Inc., founded in 2021, is a burgeoning player in the fields of Biotechnology, Health Care, and Life Sciences, with its headquarters in the United States. The company is at the forefront of developing next-generation targeted radiation therapies, utilizing a proprietary modular te...

Anchiano Therapeutics logo

About Anchiano Therapeutics

Anchiano Therapeutics, established in 2004, is a biopharmaceutical company based in the United States. The company operates at the intersection of Biotechnology, Health Care, and Medical Devices, focusing on the discovery, development, and commercialization of novel targeted cancer therapies. Their...

We will tell you when either one moves

BounceWatch watches Abdera Therapeutics and Anchiano Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Abdera Therapeutics and Anchiano Therapeutics — by email.

Frequently Asked Questions

Abdera Therapeutics. Anchiano Therapeutics — Dedicated to the discovery, development, and commercialization of novel targeted therapies to treat cancer . Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Abdera Therapeutics has raised $150.00M while Anchiano Therapeutics has raised $42.00M.
Abdera Therapeutics and Anchiano Therapeutics operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Abdera Therapeutics with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Abdera Therapeutics on 9 Jun 2026, and Anchiano Therapeutics on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes